FDA Clears Masimo’s Stork Baby Monitoring System for OTC Use
With the clearance, Stork is available for at-home monitoring of oxygen saturation, pulse rate, and skin temperature in babies without a prescription.
With the clearance, Stork is available for at-home monitoring of oxygen saturation, pulse rate, and skin temperature in babies without a prescription.
With the clearance, Stork is available for at-home monitoring of oxygen saturation, pulse rate, and skin temperature in babies without a prescription.
Read MoreThe FDA granted 510(k) clearance to Masimo’s Stork, a baby monitoring system, for prescription use with healthy and sick babies 0-18 months of age.
Read MoreMasimo announced the full US market release of the Stork smart home baby monitoring system, which can detect babies’ oxygen saturation, pulse rate, and temperature with accuracy and dependability.
Read More